Kusakabe T, Uesugi M, Sugiura Y
Institute for Chemical Research, Kyoto University, Japan.
Biochemistry. 1995 Aug 8;34(31):9944-50. doi: 10.1021/bi00031a017.
A double-stranded DNA cleavage mechanism by a novel enediyne type antitumor antibiotic, dynemicin A, has been investigated through sequence-dependent strand breakage of a series of duplexes containing a single nucleotide gap. We found that (1) dynemicin A breaks specifically at the 3'-shifted position by one base opposite the gap, (2) the strong cleavage is detected at 5'-Pu_Pu/3'-PyPuPy sequences, and (3) dynemicin H (aromatized form of dynemicin A) gives only a small inhibition effect (20%) on the cleavage of gapped duplex by dynemicin A. The long half-life of aromatization of dynemicin A (118 min, in the presence of DNA) obtained from HPLC analysis provides enough time for the second cleavage. The present results strongly indicate a two-step mechanism for the double-stranded DNA scission of dynemicin A. Namely, this double-stranded break is caused by two drug molecules, each of which cuts one DNA strand.
通过一系列含有单个核苷酸缺口的双链体的序列依赖性链断裂,对一种新型烯二炔类抗肿瘤抗生素——力达霉素A的双链DNA切割机制进行了研究。我们发现:(1)力达霉素A在缺口对面一个碱基处的3' 位移位置特异性断裂;(2)在5'-Pu_Pu/3'-PyPuPy序列处检测到强烈切割;(3)力达霉素H(力达霉素A的芳构化形式)对力达霉素A切割缺口双链体的抑制作用很小(20%)。从高效液相色谱分析中获得的力达霉素A芳构化的长半衰期(在有DNA存在时为118分钟)为第二次切割提供了足够的时间。目前的结果有力地表明了力达霉素A双链DNA断裂的两步机制。也就是说,这种双链断裂是由两个药物分子引起的,每个分子切割一条DNA链。